Exact Sciences Will Acquire Genomic Health In $2.8B Deal

Exact Sciences Will Acquire Genomic Health In $2.8B Deal

Exact Sciences Corp. (EXASwill acquire Genomic Health, Inc. (GHDX) for $72 per share in a cash and stock transaction valued at $2.8 billion.

The transaction has been unanimously approved by the board of directors of both companies and is expected to be completed by the end of 2019.

Upon closing of the deal, Exact Sciences shareholders are expected to own approximately 91% of the combined company, and Genomic Health stockholders are expected to own approximately 9%. Genomic Health stockholders will receive $27.50 in cash and $44.50 in shares of Exact Sciences stock.

Exact Sciences shares are trading down 4.6% at $112.45 in Monday’s pre-market session. The stock has a 52-week high of $121.98 and a 52-week low of $47.78.

How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.